Literature DB >> 5342365

Drug inhibition of catecholamine-induced metabolic effects in humans.

D B Hunninghake, D L Azarnoff, D Waxman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5342365     DOI： 10.1111/j.1749-6632.1967.tb41265.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

Review 1.  Current status of beta-blocking drugs in the treatment of anxiety disorders.

Authors:  P Tyrer
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

3.  Positive correlation of responsiveness to catecholamines of the rat liver glycogenolytic receptor with other alpha-receptor responses.

Authors:  A Arnold; J P McAuliff
Journal:  Experientia       Date:  1968-07-15

4.  Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.

Authors:  H Vorum; H R Jørgensen; R Brodersen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.